Picture of 4D Molecular Therapeutics logo

FDMT — 4D Molecular Therapeutics News Story

0.000.00%
us flag iconLast trade - 00:00
HealthcareSpeculativeMid CapMomentum Trap

Brief: 4D Molecular Therapeutics Q3 Net Income USD -78.056 Million Vs. IBES Estimate USD -74.2 Million




BRIEF-4D Molecular Therapeutics Q3 Net Income USD -78.056 Million Vs. IBES Estimate USD -74.2 Million


Nov 12 (Reuters) - 4D Molecular Therapeutics Q3 basic EPS USD -1.08.

  • Q3 operating expenses USD 85.363 million
  • Q3 revenue USD 4.145 million vs. IBES estimate USD 2.7 million
  • Q3 operating income USD -81.218 million vs. IBES estimate USD -79 million

Recent news on 4D Molecular Therapeutics

See all news